An interventional study of home based self paced walking program in Cancer and Fatigue, sponsored by Johns Hopkins University. Completed at 1 site in United States. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2018-12-20.
Sponsored by Johns Hopkins University · Not applicable, Interventional, and Other
The purpose of this randomized controlled trial is to determine the effects of a nurse-directed, home-based walking exercise program to mitigate fatigue and maintain physical functioning during adjuvant therapy for cancer. The sample will be randomized into exercise (EX) or usual care (UC) groups. The independent study variable is participation in a walking exercise program. Outcomes include: fatigue, sleep disturbance, emotional distress, physical functioning and quality of life. The effects of the walking exercise program will be evaluated using self-report questionnaires administered pre- and post-treatment, patient diaries, and symptoms assessments at defined intervals during adjuvant therapy
1,860 studies on the registry are indexed under Fatigue; 376 are open to participants now.
This study's planned enrollment of 140 is above the median of 54 across 1,440 interventional studies indexed under Fatigue.
Browse Fatigue studies →Johns Hopkins University is the lead sponsor of 1,783 studies on the registry; 313 are open to participants now.
Of its 203 completed or terminated interventional studies of FDA-regulated products, 140 (69%) have results posted.
Counted across the registry records on this site, refreshed daily.
Confirmed diagnosis of cancer (Stage 1,2,or 3),
21 years of age or older,
Free of cognitive or physical deficits that would preclude entry into study,
not currently exercising 120 min/wk or more
Exclusion Criteria:
Concurrent major health problems or disabilities that would limit participation in an exercise program.
Stage 4 cancer (metastisis)
This study is completed, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Johns Hopkins University